Literature DB >> 33403049

A novel prognosis marker based on combined preoperative carcinoembryonic antigen and systemic inflammatory response for resectable gastric cancer.

Yubin Ma1, Junpeng Lin2, Jianxian Lin2, Junfang Hou1, Qin Xiao1, Fang Yu1, Zhijun Ma1, Ping Li2, Ruhong Tu2, Jianwei Xie2, Chaohui Zheng2, Su Yan1, Changming Huang2.   

Abstract

Background: Carcinoembryonic antigen (CEA) is one of the important indexes for the diagnosis and prognosis of gastrointestinal cancer. Systemic inflammatory response (SIR) is closely related to the occurrence and development of gastrointestinal cancer.
Methods: A total of 803 patients who underwent radical gastrectomy in Qinghai University Affiliated Hospital from January 2012 to December 2016 were included as training set. Multivariable Cox proportional hazard regression was used to identify associations with outcome of gastric cancer (GC). CNLR was established by combining CEA and the neutrophils to lymphocytes ratio (NLR, a typical parameter in SIR) to generate a novel prognostic score system and its prognostic value was externally validated.
Results: Multivariate analysis showed that CEA and NLR were independent prognostic factors for GC patients (both p < 0.05). A higher CNLR was significantly associated with older age, male sex, larger tumor size, vascular invasion and advanced stages (all p < 0.05). Patients with higher CNLR had poor prognosis than those with lower CNLR (p < 0.05). Multivariate analysis showed that CNLR was an independent prognostic factor (p < 0.05). Incorporation of the CNLR into a prognostic model including age and TNM stage generated a nomogram, which predicted accurately 3- and 5-year survival for GC patients. And similar results were obtained in the external validation set. Conclusions: The CNLR prognostic scoring system established by combining CEA and NLR is an independent prognostic factor for GC, which can be incorporated into the traditional TNM staging to improve the prediction of long-term survival outcomes. © The author(s).

Entities:  

Keywords:  carcinoembryonic antigen; gastric cancer; nomogram; prognosis; systemic inflammatory response

Year:  2021        PMID: 33403049      PMCID: PMC7778548          DOI: 10.7150/jca.52299

Source DB:  PubMed          Journal:  J Cancer        ISSN: 1837-9664            Impact factor:   4.207


  33 in total

1.  Japanese gastric cancer treatment guidelines 2010 (ver. 3).

Authors: 
Journal:  Gastric Cancer       Date:  2011-06       Impact factor: 7.370

2.  Prognostic value of early postoperative tumor marker response in gastric cancer.

Authors:  Dong Hyuk Nam; Yong Kang Lee; Jun Chul Park; Hyuk Lee; Sung Kwan Shin; Sang Kil Lee; Yong Chan Lee; Jae-Ho Cheong; Woo Jin Hyung; Sung Hoon Noh; Choong Bai Kim
Journal:  Ann Surg Oncol       Date:  2013-06-27       Impact factor: 5.344

3.  Value of preoperative inflammation-based prognostic scores in predicting overall survival and disease-free survival in patients with gastric cancer.

Authors:  Paolo Aurello; Simone Maria Tierno; Giammauro Berardi; Federico Tomassini; Paolo Magistri; Francesco D'Angelo; Giovanni Ramacciato
Journal:  Ann Surg Oncol       Date:  2014-02-11       Impact factor: 5.344

4.  Preoperative positivity of serum tumor markers is a strong predictor of hematogenous recurrence of gastric cancer.

Authors:  D Marrelli; E Pinto; A De Stefano; G de Manzoni; M Farnetani; L Garosi; F Roviello
Journal:  J Surg Oncol       Date:  2001-12       Impact factor: 3.454

5.  ESMO Consensus Guidelines for management of patients with colon and rectal cancer. a personalized approach to clinical decision making.

Authors:  H J Schmoll; E Van Cutsem; A Stein; V Valentini; B Glimelius; K Haustermans; B Nordlinger; C J van de Velde; J Balmana; J Regula; I D Nagtegaal; R G Beets-Tan; D Arnold; F Ciardiello; P Hoff; D Kerr; C H Köhne; R Labianca; T Price; W Scheithauer; A Sobrero; J Tabernero; D Aderka; S Barroso; G Bodoky; J Y Douillard; H El Ghazaly; J Gallardo; A Garin; R Glynne-Jones; K Jordan; A Meshcheryakov; D Papamichail; P Pfeiffer; I Souglakos; S Turhal; A Cervantes
Journal:  Ann Oncol       Date:  2012-10       Impact factor: 32.976

Review 6.  Carcinoembryonic antigen in the staging and follow-up of patients with colorectal cancer.

Authors:  Mitchell J Goldstein; Edith Peterson Mitchell
Journal:  Cancer Invest       Date:  2005       Impact factor: 2.176

7.  Preoperative neutrophil-to-lymphocyte ratio is a predictor of survival after hepatectomy for hepatocellular carcinoma: a retrospective analysis.

Authors:  Yohei Mano; Ken Shirabe; Yo-Ichi Yamashita; Norifumi Harimoto; Eiji Tsujita; Kazuki Takeishi; Shinichi Aishima; Toru Ikegami; Tomoharu Yoshizumi; Takeharu Yamanaka; Yoshihiko Maehara
Journal:  Ann Surg       Date:  2013-08       Impact factor: 12.969

8.  Comprehensive molecular characterization of clinical responses to PD-1 inhibition in metastatic gastric cancer.

Authors:  Seung Tae Kim; Razvan Cristescu; Adam J Bass; Kyoung-Mee Kim; Justin I Odegaard; Kyung Kim; Xiao Qiao Liu; Xinwei Sher; Hun Jung; Mijin Lee; Sujin Lee; Se Hoon Park; Joon Oh Park; Young Suk Park; Ho Yeong Lim; Hyuk Lee; Mingew Choi; AmirAli Talasaz; Peter Soonmo Kang; Jonathan Cheng; Andrey Loboda; Jeeyun Lee; Won Ki Kang
Journal:  Nat Med       Date:  2018-07-16       Impact factor: 53.440

9.  Epithelial-mesenchymal transition (EMT) induced by TNF-α requires AKT/GSK-3β-mediated stabilization of snail in colorectal cancer.

Authors:  Hao Wang; Hong-Sheng Wang; Bin-Hua Zhou; Cui-Lin Li; Fan Zhang; Xian-Feng Wang; Ge Zhang; Xian-Zhang Bu; Shao-Hui Cai; Jun Du
Journal:  PLoS One       Date:  2013-02-19       Impact factor: 3.240

10.  Increased neutrophil-lymphocyte ratio is a poor prognostic factor in patients with primary operable and inoperable pancreatic cancer.

Authors:  M Stotz; A Gerger; F Eisner; J Szkandera; H Loibner; A L Ress; P Kornprat; W AlZoughbi; W A Zoughbi; F S Seggewies; C Lackner; T Stojakovic; H Samonigg; G Hoefler; M Pichler
Journal:  Br J Cancer       Date:  2013-06-25       Impact factor: 9.075

View more
  3 in total

1.  Perioperative lymphocyte-to-monocyte ratio changes plus CA199 in predicting the prognosis of patients with gastric cancer.

Authors:  Wenjing Zhao; Guoxin Mao; Yueyue Zhu
Journal:  J Gastrointest Oncol       Date:  2022-06

2.  Construction and Validation of Convenient Clinicopathologic Signatures for Predicting the Prognosis of Stage I-III Gastric Cancer.

Authors:  Weiqiang You; Zerong Cai; Nengquan Sheng; Li Yan; Huihui Wan; Yongkun Wang; Jian Ouyang; Lu Xie; Xiaojian Wu; Zhigang Wang
Journal:  Front Oncol       Date:  2022-03-24       Impact factor: 6.244

3.  Expression Levels and Clinical Significance of Serum miR-497, CEA, CA24-2, and HBsAg in Patients with Colorectal Cancer.

Authors:  Yan Liu; Jie Chen
Journal:  Biomed Res Int       Date:  2022-08-11       Impact factor: 3.246

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.